Go

Newsroom


Preventing Kidney Transplant Rejection

Rabbit-Derived Drug Prevents Kidney Transplant Rejection

A study headed by Daniel C. Brennan, MD, director of transplant nephrology at Washington University School of Medicine and medical director of kidney transplant at Barnes-Jewish Hospital, shows that using a rabbit-derived drug to prevent acute rejection of donated kidneys can reap long-term benefits.

The research describes a multi-center, international clinical trial comparing two “induction agents,” drugs given to kidney transplant patients who have received donor organs from deceased donors.

The agents are given during the first several days after surgery in order to avoid delayed functioning of the organ and to prevent acute rejection.

Living vs. Deceased Donation

Should someone on the transplant list try for a living donor or wait for a deceased donor? Find out in this edition of "Explore Transplant" with Amy Waterman, PhD.

 

Sign Up Today for Free e-Newsletters

Find a doctor or make an appointment:
General Information: (314) 747-3000
One Barnes-Jewish Hospital Plaza
St. Louis, MO 63110
© Copyright 1997-2014, Barnes-Jewish Hospital. All Rights Reserved.